• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“达康盾”宫内节育器是一种安全有效的节育器吗?病例对照研究结果与临床试验研究结果之间的冲突。

Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings.

作者信息

Mumford S D, Kessel E

机构信息

Center for Research on Population and Security, Research Triangle Park, North Carolina.

出版信息

Fertil Steril. 1992 Jun;57(6):1151-76. doi: 10.1016/s0015-0282(16)55068-7.

DOI:10.1016/s0015-0282(16)55068-7
PMID:1601137
Abstract

OBJECTIVE

To compare the findings of the case-control and cohort studies used to indict the Dalkon Shield (A.H. Robins Company, Inc., Richmond, VA) with the findings of the Dalkon Shield clinical trials.

DATA IDENTIFICATION

All published reports on the Dalkon Shield were identified through MEDLARS system (United States National Library of Medicine) searches and by cross checking all references in these reports. The same approach was used to identify all case-control and cohort studies of the purported relationship between intrauterine devices (IUDs) and pelvic inflammatory disease (PID).

STUDY SELECTION

Only studies of interval patients that included 50 or more women and 6 or more months of follow up that computed standard IUD event rates (rates of pregnancy and expulsion and removal for pain and bleeding) were selected for this study. All case-control and cohort studies identified were included except two case-control studies that included women with sterile chronic salpingitis.

RESULTS

The 16 case-control and 2 cohort studies found or suggested that the Dalkon Shield increased the risk of PID. The 71 clinical trials of the Dalkon Shield show that when this device is inserted by an experienced clinician it is a safe and effective contraceptive method, comparable with other IUDs used at the time. There was no evidence of an increased risk of PID found in these clinical trials.

CONCLUSIONS

This study offers convincing evidence that the indictment of the Dalkon Shield was a mistake. Additionally, this study shows that physician skill and experience is far more important to successful IUD insertion than previously recognized, a finding with considerable implications for IUD study designs and for marketing strategies.

摘要

目的

比较用于指控盾形节育器(弗吉尼亚州里士满市A.H.罗宾斯公司生产)的病例对照研究和队列研究结果与盾形节育器临床试验结果。

数据识别

通过医学文献分析和检索系统(美国国立医学图书馆)搜索,并交叉核对这些报告中的所有参考文献,识别出所有已发表的关于盾形节育器的报告。采用相同方法识别所有关于宫内节育器(IUD)与盆腔炎(PID)之间所谓关系的病例对照研究和队列研究。

研究选择

本研究仅选择对间隔期患者进行的研究,这些研究纳入了50名或更多女性且随访时间为6个月或更长时间,并计算了标准宫内节育器事件发生率(妊娠率、因疼痛和出血而排出及取出率)。除两项纳入患有无菌性慢性输卵管炎女性的病例对照研究外,所有识别出的病例对照研究和队列研究均被纳入。

结果

16项病例对照研究和2项队列研究发现或表明盾形节育器会增加盆腔炎风险。盾形节育器的71项临床试验表明,当由经验丰富的临床医生插入该装置时,它是一种安全有效的避孕方法,与当时使用的其他宫内节育器相当。在这些临床试验中未发现盆腔炎风险增加的证据。

结论

本研究提供了令人信服的证据,证明对盾形节育器的指控是一个错误。此外,本研究表明,医生的技能和经验对成功插入宫内节育器远比之前认识到的更为重要,这一发现对宫内节育器研究设计和营销策略具有重要意义。

相似文献

1
Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings.“达康盾”宫内节育器是一种安全有效的节育器吗?病例对照研究结果与临床试验研究结果之间的冲突。
Fertil Steril. 1992 Jun;57(6):1151-76. doi: 10.1016/s0015-0282(16)55068-7.
2
Another look at the Dalkon Shield: meta-analysis underscores its problems.再看达康盾宫内节育器:荟萃分析凸显其问题。
Contraception. 1993 Jul;48(1):1-12. doi: 10.1016/0010-7824(93)90060-k.
3
Pelvic inflammatory disease with intrauterine device use: a reassessment.使用宫内节育器与盆腔炎:一项重新评估
Fertil Steril. 1989 Jan;51(1):1-11.
4
Medical records in litigation: the Dalkon Shield story.诉讼中的医疗记录:达康盾节育器事件
AMRO. 1992 Feb;32(5):11-4.
5
Earth, motherhood, and the intrauterine device.
Fertil Steril. 1992 Jun;57(6):1177-9. doi: 10.1016/s0015-0282(16)55069-9.
6
Long-term study of the safety of the Dalkon Shield and Gyne-T 200 intrauterine devices.Dalkon Shield和Gyne-T 200宫内节育器安全性的长期研究。
CMAJ. 1986 Apr 1;134(7):747-51.
7
An association between the Dalkon Shield and complicated pregnancies among women hospitalized for intrauterine contraceptive device--related disorders.在因宫内节育器相关疾病住院的女性中,达康盾与复杂妊娠之间的关联。
Am J Obstet Gynecol. 1976 May 1;125(1):83-6. doi: 10.1016/0002-9378(76)90897-8.
8
The Dalkon Shield debate.达康盾争议
Conn Med. 1983 Mar;47(3):138-41.
9
A prospective randomized comparative trial of the Gravigard, Latex Leaf, Dalkon Shield and Multiload Cu 250 IUDs.一项关于Gravigard、乳胶叶形、Dalkon Shield和Multiload Cu 250宫内节育器的前瞻性随机对照试验。
Aust N Z J Obstet Gynaecol. 1986 Aug;26(3):228-32. doi: 10.1111/j.1479-828x.1986.tb01573.x.
10
Postpartum IUDS: keys for success.产后宫内节育器:成功的关键
Contraception. 1992 Apr;45(4):351-61. doi: 10.1016/0010-7824(92)90057-z.

引用本文的文献

1
Contraception and Abortion Care for People Living With HIV: A Clinical Guide for Reproductive Health Practitioners.《HIV 感染者避孕与人工流产服务:生殖健康从业者临床指南》
J Midwifery Womens Health. 2023 Nov-Dec;68(6):719-727. doi: 10.1111/jmwh.13575. Epub 2023 Oct 30.
2
Pharmaceuticals and modern statecraft in South Africa: the cases of opium, thalidomide and contraception.南非的药品与现代治国方略:鸦片、沙利度胺及避孕案例
Med Humanit. 2018 Dec;44(4):253-262. doi: 10.1136/medhum-2018-011478.
3
New developments in intrauterine device use: focus on the US.
宫内节育器使用的新进展:聚焦美国。
Open Access J Contracept. 2016 Sep 13;7:127-141. doi: 10.2147/OAJC.S85755. eCollection 2016.
4
Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS.左炔诺孕酮宫内节育系统的避孕和非避孕用途的安全性、有效性和患者可接受性。
Int J Womens Health. 2010 Aug 9;1:45-58. doi: 10.2147/ijwh.s4350.